ENDO HEALTH SOLUTIONS INC

Inactive Instrument

Analyst Reco. Endo Health Solutions Inc Nasdaq

Equities

US29264F2056

End-of-day quote Nasdaq Other stock markets
- ^USD	-

05-06	North American Morning Briefing : Stock Futures -2-	DJ
03-22	Fourth Amended Joint Reorganization Plan Approved for Endo International plc	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : Stock Futures -2-	05-06	DJ
BMO Capital Lowers Price Target for Endo International to $2 From $4, Maintains Market Perform Rating	22-05-09	MT
Barclays Trims Endo International's Price Target to $1 From $2, Maintains Underweight Rating	22-05-09	MT
Piper Sandler Downgrades Endo International to Underweight From Neutral, Lowers PT to $1 From $3	22-05-06	MT
Citigroup Adjusts Endo International's Price Target to $6 From $11, Reiterates Buy Rating	22-03-09	MT
BMO Capital Adjusts Endo International Price Target to $4 From $8, Maintains Market Perform Rating	22-03-03	MT
Piper Sandler Adjusts Endo International Price Target to $3 From $5, Maintains Neutral Rating	22-03-02	MT
Barclays Downgrades Endo International to Underweight from Equalweight, Adjusts Price Target to $2 from $5	22-03-02	MT
Barclays Adjusts Endo International's Price Target to $5 From $7, Keeps Equalweight Rating	21-12-16	MT
Endo International : S&P Downgrades Endo International Rating to 'CCC+' From 'B-' on Vasostrict Trial Outcome; Outlook Negative	21-09-02	MT
ENDO INTERNATIONAL : Piper Sandler Downgrades Endo International to Neutral From Overweight, Adjusts Price Target to $3 From $10	21-08-31	MT
ENDO INTERNATIONAL : RBC Cuts Price Target on Endo International to $5 From $6, Reiterates Sector Perform	21-08-09	MT
ENDO INTERNATIONAL : Citigroup Adjusts Price Target on Endo International to $11 From $10, Maintains Buy Rating	21-05-17	MT
ENDO INTERNATIONAL : RBC Cuts Price Target on Endo International to $6 From $7, Noting 'Persistent Overhang' of Opioid Litigation; Sector Perform Kept	21-05-10	MT
ENDO INTERNATIONAL : Morgan Stanley Adjusts Price Target on Endo International to $7 From $5, Maintains Underweight Rating	21-03-03	MT
ENDO INTERNATIONAL : RBC Capital Adjusts Endo International's Price Target to $7 From $5, Maintains Sector Perform Rating	21-03-01	MT
ENDO INTERNATIONAL : Morgan Stanley Adjusts Price Target on Endo International to $5 From $4, Maintains Underweight Rating	20-12-21	MT
ENDO INTERNATIONAL : Morgan Stanley Lifts Endo International Price Target to $4 From $3, Maintains at Underweight	20-11-12	MT
Wall St. closes at 2016 high as Fed signals fewer rate hikes	16-03-16	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW